Literature DB >> 21254064

In vitro assessment of the formation of ceftriaxone-calcium precipitates in human plasma.

Hans-Rudolf Schmutz1, Pascal Detampel, Theo Bühler, André Büttler, Benjamin Gygax, Jörg Huwyler.   

Abstract

Ceftriaxone is a third-generation cephalosporin antibiotic, which has a broad spectrum of bactericidal activity. Ceftriaxone is highly soluble as a sodium salt, but far less soluble as a calcium salt. Incompatibility of ceftriaxone with calcium and the possible formation of precipitates have been stated in the product label from early on. It was the objective of the present in vitro study to further assess the risk of precipitation of calcium-ceftriaxone in human plasma. Analytical methods were developed (high-performance liquid chromatography and flame atomic absorption spectroscopy) to quantitate calcium and ceftriaxone in human plasma supernatants and human plasma precipitates. Using high concentrations of ceftriaxone (10 mmol/L) and calcium (4.2 mmol/L) did not result in any precipitation after 2 h incubation in human plasma at 37 °C. Under conditions of forced precipitation only, formation of precipitation was observed. The identity of the precipitated material was confirmed by energy-dispersive X-ray analysis and Fourier transform infrared spectroscopy. We conclude that calcium-ceftriaxone in human plasma has an apparent kinetic solubility product constant of greater than 0.42 × 10(-4) (mol/L)(2), which exceeds the normal thermodynamic solubility product in water by a factor of 26. Under these conditions, the formation of plasma precipitates is unlikely.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21254064     DOI: 10.1002/jps.22466

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

Review 1.  Characterizing ceftriaxone-induced urolithiasis and its associated acute kidney injury: an animal study and Chinese clinical systematic review.

Authors:  Yifan Zhang; Benxiang Ning; Huaijun Zhu; Xiaoming Cong; Leqing Zhou; Qiang Wang; Liming Zhang; Xizhao Sun
Journal:  Int Urol Nephrol       Date:  2016-04-28       Impact factor: 2.370

Review 2.  Engineered nanomaterial uptake and tissue distribution: from cell to organism.

Authors:  Helene Kettiger; Angela Schipanski; Peter Wick; Jörg Huwyler
Journal:  Int J Nanomedicine       Date:  2013-08-27

3.  In vitro study of new combinations for local antibiotic therapy with calcium sulphate - Near constant release of ceftriaxone offers new treatment options.

Authors:  Peter Wahl; Karolin Rönn; Marc Bohner; Laurent A Decosterd; Christoph Meier; Michel Schläppi; Sandrine Festa; Emanuel Gautier
Journal:  J Bone Jt Infect       Date:  2018-10-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.